FDA Links 10 Child Deaths to COVID-19 Vaccines, Strengthens Oversight Measures
The New York Times has reported on an internal memorandum from the U.S. Food and Drug Administration (FDA) indicating that at least 10 children may have died as a result of COVID-19 vaccines, with myocarditis identified as a possible cause.
According to the report, the memo, authored by the FDA's Chief Medical and Scientific Officer, Dr. Vinay Prasad, did not disclose the ages of the deceased children or any underlying health conditions, nor did it specify the vaccine manufacturers involved.
Dr. Prasad described these findings as a "significant discovery," and announced plans to enhance oversight of vaccines, which will include the necessity of conducting randomized studies across all demographics.
This revelation comes at a time when vaccination policies in the U.S. are undergoing significant changes. Health Secretary Robert Kennedy Jr. has revised official recommendations, limiting vaccine access to the most vulnerable populations, including individuals aged 65 and older and those with pre-existing health conditions.
It is noteworthy that Secretary Kennedy has long been a vocal opponent of vaccines prior to taking office, often linking them to autism and advocating for a reform of national vaccination policies.
Additionally, the report indicated that the Vaccine Advisory Committee of the Centers for Disease Control and Prevention (CDC) is scheduled to convene in the coming days to discuss these developments.
Dr. Vinay Prasad, an oncologist, has been one of the most prominent critics of COVID-19 vaccine mandates and mask usage in the U.S. He returned to his role as Chief Medical and Scientific Officer of the FDA last September, where he advises the commissioner and senior officials on emerging medical and scientific issues.
The U.S. Department of Health and Human Services, which includes the FDA, did not respond to Reuters' request for comment on this report at the time of publication.
